1-[5-[2-(difluoromethoxy)-6-[5-(2-methoxy-6-methyl-4-pyridinyl)-4-[(1-propan-2-ylpyrazol-3-yl)sulfonylcarbamoylamino]-2,3-dihydro-1H-inden-1-yl]-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea
C45H48F2N10O8S2 — CID 155313257
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[5-[2-(difluoromethoxy)-6-[5-(2-methoxy-6-methyl-4-pyridinyl)-4-[(1-propan-2-ylpyrazol-3-yl)sulfonylcarbamoylamino]-2,3-dihydro-1H-inden-1-yl]-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea
1-[5-[2-(difluoromethoxy)-6-[5-(2-methoxy-6-methyl-4-pyridinyl)-4-[(1-propan-2-ylpyrazol-3-yl)sulfonylcarbamoylamino]-2,3-dihydro-1H-inden-1-yl]-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea (PubChem CID 155313257) has the molecular formula C45H48F2N10O8S2 and a molecular weight of 959.07 g/mol. Its IUPAC name is 1-[5-[2-(difluoromethoxy)-6-[5-(2-methoxy-6-methyl-4-pyridinyl)-4-[(1-propan-2-ylpyrazol-3-yl)sulfonylcarbamoylamino]-2,3-dihydro-1H-inden-1-yl]-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea.
Molecular Properties
| Compound Name | 1-[5-[2-(difluoromethoxy)-6-[5-(2-methoxy-6-methyl-4-pyridinyl)-4-[(1-propan-2-ylpyrazol-3-yl)sulfonylcarbamoylamino]-2,3-dihydro-1H-inden-1-yl]-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea |
|---|---|
| PubChem CID | 155313257 |
| Molecular Formula | C45H48F2N10O8S2 |
| Molecular Weight | 959.07 g/mol |
| Exact Mass | 958.31 |
| IUPAC Name | 1-[5-[2-(difluoromethoxy)-6-[5-(2-methoxy-6-methyl-4-pyridinyl)-4-[(1-propan-2-ylpyrazol-3-yl)sulfonylcarbamoylamino]-2,3-dihydro-1H-inden-1-yl]-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea |
| SMILES | COc1cc(-c2ccc3c(c2NC(=O)NS(=O)(=O)c2ccn(C(C)C)n2)CCC3c2cc(-c3ccc4c(c3NC(=O)NS(=O)(=O)c3ccn(C(C)C)n3)CCC4)cc(OC(F)F)n2)cc(C)n1 |
| InChI | InChI=1S/C45H48F2N10O8S2/c1-24(2)56-18-16-39(52-56)66(60,61)54-44(58)50-41-30-9-7-8-27(30)10-11-31(41)29-21-36(49-38(23-29)65-43(46)47)34-14-15-35-33(34)13-12-32(28-20-26(5)48-37(22-28)64-6)42(35)51-45(59)55-67(62,63)40-17-19-57(53-40)25(3)4/h10-13,16-25,34,43H,7-9,14-15H2,1-6H3,(H2,50,54,58)(H2,51,55,59) |
| InChIKey | DIJXBRSJSVJWJQ-UHFFFAOYSA-N |
| XLogP | 7.87 |
| TPSA | 230.42 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 67 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 959.07 |
| LogP ≤ 5 | 7.87 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155313257 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.